Pharma vs FDA Actions
Side-by-side coverage analysis for Pharma and FDA Actions.
This comparison applies the same classification pipeline used across every story on this site, which scores each linked entity at a minimum 35 percent relevance threshold before it is surfaced. According to our editorial methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
Pharma
Drug pricing, commercialization, pharma industry news
- Stories
- 20
- Avg Impact
- 6.5/10
- Dominant Tone
- Neutral
- Latest
- 1d ago
FDA Actions
Approvals, rejections, priority reviews
- Stories
- 20
- Avg Impact
- 7/10
- Dominant Tone
- Bullish
- Latest
- 2d ago
Recent Headlines
Pharma
- 49-Year Species Rule Ends: Biotech’s Natural Drug Library Faces Extinction Risk
- Only 92 Deals: Big Pharma's TrumpRx Offering Covers Under 12% of Its 800+ Drug Stable
- 5,100 Suspected Cyclospora Cases Drive Demand for Rapid Diagnostics and New Therapies
- Novartis, Roche Face 50% PBS Price Cut on MS Drugs as Briumvi Triggers Review
- Multi-Target AI Alliance Targets $2.5B Potential to Redraw Pharma R&D Model
- Biotech's ESA Burden Lifted? 'Harm' Rule Ends in 60 Days, Easing Facility Permits
- Takeda Secures First ASEAN Plasma Fractionation License in $30M Indonesia Deal
- Dimerix Taps Everest for DMX-200 Asia License, Phase 3 Trial Enrolls 333 with >90% Power
- Birth Control Pill Prescriptions Fell 25% During Planned Parenthood Defunding, Hitting Pharma Markets
- Bundibugyo Ebola Strain with No Vaccine Kills 6-Month-Old, Cases Top 894
FDA Actions
- Merck’s oral PCSK9 inhibitor hits 59% LDL cut, leapfrogging injectable rivals
- Vera’s TRUTAKNA Gets FDA Nod with 42% UPCR Reduction, Awaits Kidney Data
- Cannabis Rescheduling Could Unlock $2.2B for Biotech & Pharma R&D, Challenger Says
- Pharma and Ag Biotech Face Regulatory Fog as EPA's MAHA Agenda Hits 8-Month Void
- Moderna's PDUFA Aug 5 Looms as 3 Biotechs Return Up to 230% in H1 2026
- HYFT Stock Jumps 2.3% on Patent to Own the Data Layer for AI Drug Discovery
- AIIMS Recruits 460+ Researchers, Supercharging India’s Biomedical Pipeline
- First Nicotine Pouch MRTP: How ZYN’s 10 Flavors Achieved FDA Reduced‑Exposure Status
- Roundup Ruling: 7-2 SCOTUS Verdict Reduces Bayer's Liability by Billions
- $6.5B Fraud Sweep Nabs Genetic Testing Scams: Biotech’s Compliance Wake-Up Call